Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease
- 1 February 1999
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 353 (9151) , 459-461
- https://doi.org/10.1016/s0140-6736(98)03339-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion ProteinNew England Journal of Medicine, 1997
- Immunoregulatory role of interleukin 10 in patients with inflammatory bowel diseaseGastroenterology, 1995
- Disease Activity Courses in a Regional Cohort of Crohn's Disease PatientsScandinavian Journal of Gastroenterology, 1995
- Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritisThe Lancet, 1994
- Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's diseaseClinical and Experimental Immunology, 1993
- Microscopic activity in ulcerative colitis: what does it mean?Gut, 1991
- Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestineClinical and Experimental Immunology, 1990
- Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.Gut, 1990
- Predictors of acute relapse of Crohn's diseaseDigestive Diseases and Sciences, 1987
- On the Kolmogorov-Smirnov Test for Normality with Mean and Variance UnknownJournal of the American Statistical Association, 1967